Technical Analysis for ARCH - Arch Biopartners Inc

Grade Last Price % Change Price Change
A 2.83 9.27% 0.240
ARCH closed up 9.27 percent on Monday, October 25, 2021, on 51 percent of normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Up
Historical ARCH trend table...

Date Alert Name Type % Chg
1,2,3 Pullback Bullish Bullish Swing Setup 0.00%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Inside Day Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Overbought Stochastic Strength 0.00%
Volume Surge Other 9.27%
Wide Range Bar Range Expansion 9.27%
Wide Bands Range Expansion 9.27%
Overbought Stochastic Strength 9.27%
Calm After Storm Range Contraction -0.35%
Older End-of-Day Signals for ARCH ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Possible Inside Day about 17 hours ago
Up 1 ATR about 21 hours ago
10 DMA Support about 21 hours ago
Down 1% about 21 hours ago
Up 5% about 21 hours ago
View Earlier Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Arch Biopartners Inc Description

Arch Biopartners Inc. is a portfolio-based biotechnology company. The Company is focused on the development of technologies that make a medical or commercial impact. Its technology platforms include AB569, MetaBlok, Arch Inflammation, Borg and MetaMx. AB569 is a drug candidate for treating antibiotic resistant bacterial infections, primarily in the lungs and urinary tract. MetaBlok is a drug candidate targeting sepsis, cancer metastasis and inflammation based diseases. Arch Inflammation is a treatment for chronic kidney and bowel diseases caused by non-infectious inflammation. Arch Inflammation is focused on developing anti-inflammatory small molecules that target proteins in the innate immune system. Borg is a peptide-solid surface Interface for binding of peptides to solid metal and plastic surfaces to inhibit biofilm formation. MetaMx are synthetic molecules that target brain tumor initiating cells and invasive glioma cells. The Company has not generated any revenues.


Sector: Healthcare
Industry: Biotechnology
Keywords: Metal Health Medicine Drug Disease Biotechnology Cancer Diseases Plastic Immunology Infection Proteins Tumor Bacteria Peptide Brain Immune System Infections Antibiotic Inflammation Peptides Biofilm Brain Tumor Technology Platforms Bacterial Infection Chronic Kidney Sepsis

Is ARCH a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 2.98
52 Week Low 1.12
Average Volume 55,309
200-Day Moving Average 1.465
50-Day Moving Average 1.925
20-Day Moving Average 2.216
10-Day Moving Average 2.618
Average True Range 0.168
ADX 46.86
+DI 32.628
-DI 15.642
Chandelier Exit (Long, 3 ATRs) 2.476
Chandelier Exit (Short, 3 ATRs) 2.184
Upper Bollinger Bands 3.102
Lower Bollinger Band 1.330
Percent B (%b) 0.85
BandWidth 79.937
MACD Line 0.286
MACD Signal Line 0.227
MACD Histogram 0.0587
Fundamentals Value
Market Cap 172.01 Million
Num Shares 60.8 Million
EPS -0.04
Price-to-Earnings (P/E) Ratio -76.49
Price-to-Sales 601.44
Price-to-Book 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.310
Resistance 3 (R3) 3.273 3.077 3.230
Resistance 2 (R2) 3.077 2.954 3.095 3.203
Resistance 1 (R1) 2.953 2.879 3.015 2.990 3.177
Pivot Point 2.757 2.757 2.788 2.775 2.757
Support 1 (S1) 2.633 2.634 2.695 2.670 2.483
Support 2 (S2) 2.437 2.559 2.455 2.457
Support 3 (S3) 2.313 2.437 2.430
Support 4 (S4) 2.350